Recent Updates — ONMDW

OneMedNet received written notice from Nasdaq that it has regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. This follows a previous notification of non-compliance in April 2026, which provided a grace period until October 12, 2026. Compliance was demonstrated by closing bid prices at or above $1.00 per share for ten consecutive business days from September 29 through October 12, 2026. The matter is now closed and no further action is required to maintain listing status. OneMedNet operates in the healthcare technology sector, providing digital health solutions.

OneMedNet Corporation filed a Certificate of Amendment to its Certificate of Incorporation to implement a 1-for-10 reverse stock split of its common stock. The transaction was approved by stockholders on September 18, 2026, and became effective at 12:01 a.m. Eastern Time on September 29, 2026. This action aims to restore compliance with Nasdaq Capital Market minimum bid price requirements for continued listing. The split reduces outstanding shares from approximately 60 million to roughly 6 million, with fractional shares rounded up to the nearest whole share. OneMedNet Corporation operates in the healthcare data technology industry, providing AI-driven real-world data platforms for regulatory and clinical decision-making.

OneMedNet Corporation entered into a standby equity purchase agreement (SEPA) with YA II PN, Ltd. (Yorkville) on July 1, 2026, allowing the company to sell up to $25 million of its common stock to Yorkville at a price equal to 97% of the market price. The agreement, which terminates in 36 months, limits each advance to the greater of 500,000 shares or 100% of the five-day average daily volume. OneMedNet Corporation operates in the healthcare technology sector, providing a network for medical device companies to connect with surgeons and surgeons' offices.